Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

242.89 +1.05 (+0.43%)
Official Closing Price Updated: 4:15 PM EST, Mar 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
News headline image
NASDAQ:PODD—A High-Growth Stock Gearing Up for Its Next Upward Move. ↗
Is INSULET CORP (NASDAQ:PODD) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
News headline image
Insulet Launches Revolutionary Omnipod® 5 in Five More Countries in Europe
From Insulet Corporation
Via Business Wire
News headline image
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 ↗
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74. 
Via Investor's Business Daily
News headline image
Insulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
From Insulet Corporation
Via Business Wire
News headline image
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
Looking Into Insulet's Recent Short Interest ↗
 
Via Benzinga
News headline image
Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout. ↗
Why INSULET CORP (NASDAQ:PODD) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
News headline image
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices ↗
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
News headline image
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Inari Medical Stock Gets RS Rating Upgrade ↗
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72. 
Via Investor's Business Daily
News headline image
Decoding 11 Analyst Evaluations For Insulet ↗
 
Via Benzinga
News headline image
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court
From Insulet Corporation
Via Business Wire
News headline image
Novocure Stock Earns 96 RS Rating ↗
On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73. 
Via Investor's Business Daily
News headline image
Peering Into Insulet's Recent Short Interest ↗
 
Via Benzinga
News headline image
NASDAQ:PODD qualifies as a high growth stock and is consolidating. ↗
INSULET CORP (NASDAQ:PODD)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
Via Chartmill
News headline image
Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
From Insulet Corporation
Via Business Wire
News headline image
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
News headline image
Top 4 Health Care Stocks That May Plunge This Quarter ↗
 
Via Benzinga
News headline image
S&P 500 Breaks 6,000 Points, Dow Soars Above 44,000, Small Caps Eye Strongest Week In 4 Years, Tesla Hits $1 Trillion: What's Driving Markets Friday? ↗
The S&P 500 index surged past the 6,000-point milestone, setting fresh record highs, and small-cap stocks are poised for their best weekly performance since April 2024 as investor optimism surrounding... 
Via Benzinga
Topics Stocks
News headline image
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues ↗
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024. 
Via Investor's Business Daily
News headline image
High growth, ROE and relative strength for NASDAQ:PODD, growth investors may appreciate this. ↗
Evaluating INSULET CORP (NASDAQ:PODD) for Growth Investment Opportunities. 
Via Chartmill
News headline image
Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)
From Insulet Corporation
Via Business Wire
News headline image
9 Analysts Have This To Say About Insulet ↗
 
Via Benzinga
News headline image
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
 
Via Benzinga
News headline image
Why NASDAQ:PODD qualifies as a high growth stock. ↗
Is INSULET CORP (NASDAQ:PODD) suited for high growth investing? 
Via Chartmill
News headline image
(PODD) - Analyzing Insulet's Short Interest ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In Insulet 10 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
From Insulet Corporation 
Via Business Wire
News headline image
Omnipod® 5 App for iPhone® Now Fully Available in the United States
From Insulet Corporation
Via Business Wire
News headline image
Is NASDAQ:PODD on the Verge of a Major Breakout as a Strong Growth Stock? ↗
Why INSULET CORP (NASDAQ:PODD) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.